Role of IL-15 and IL-21 in viral immunity: Applications for vaccines and therapies

Expert Review of Vaccines

Volumn 8, Issue 2, 2009, Pages 167-177

  Rodrigues, Luiz ^a   Bonorino, Cristina ^b  

^a CENTRO UNIVERSITÁRIO FRANCISCANO   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Adjuvant; Cytokine; Memory CD8+ T cell; Vaccine; Virus

Indexed keywords

CD27 ANTIGEN; CD28 ANTIGEN; CHEMOKINE RECEPTOR CCR7; DNA VACCINE; GAMMA INTERFERON; INTERLEUKIN 15; INTERLEUKIN 21; STAT4 PROTEIN; VIRUS VACCINE;

ADAPTIVE IMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DNA IMMUNIZATION; DRUG DESIGN; HERPES SIMPLEX VIRUS 1; HUMAN; IMMUNOMODULATION; IMMUNOREACTIVITY; IMMUNOREGULATION; INTERFERON PRODUCTION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; VACCINATION; VIRUS REACTIVATION; VIRUS RESISTANCE;

CD8-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNOTHERAPY; INTERFERON-ALPHA; INTERFERON-BETA; INTERFERON-GAMMA; INTERLEUKIN-15; INTERLEUKINS; KILLER CELLS, NATURAL; VIRAL VACCINES; VIRUS DISEASES;

EID: 60149091521     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.8.2.167     Document Type: Review

References (127)

1. Kovanen PE, Leonard WJ. Cytokines and immunodeficiency diseases: critical roles of the γc-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways. Immunol. Rev. 202, 67-83 (2004).
2. Demoulin JB, Renauld JC. Interleukin 9 and its receptor: an overview of structure and function. Int. Rev. Immunol. 16(3-4), 345-364 (1998).
3. Radwanska M, Cutler AJ, Hoving JC et al. Deletion of IL-4Rα on CD4 T cells renders BALB/c mice resistant to Leishmania major infection. PLoS Pathog 3(5), E68 (2007).
4. Trigueros C, Hozumi K, Silva-Santos B et al. Pre-TCR signaling regulates IL-7 receptor α expression promoting thymocyte survival at the transition from the double-negative to double-positive stage. Eur. J. Immunol. 33(7), 1968-1977 (2003).
5. Cao X, Shores EW, Hu-Li J et al. Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain. Immunity 2 (3), 223-238 (1995).
6. 4 T cell response against an intracellular parasite. Proc. Natl Acad. Sci. USA 103(17), 6635-6640 (2006).
7. Cui FD, Asada H, Jin ML et al. Cytokine genetic adjuvant facilitates prophylactic intravascular DNA vaccine against acute and latent herpes simplex virus infection in mice. Gene Ther. 12(2), 160-168 (2005).
8. Bolesta E, Kowalczyk A, Wierzbicki A et al. Increased level and longevity of protective immune responses induced by DNA vaccine expressing the HIV-1 Env glycoprotein when combined with IL-21 and IL-15 gene delivery. J. Immunol. 177(1), 177-191 (2006).
9. + T cells for use in adoptive immunotherapy of established tumors. Nat. Med. 12(3), 335-341 (2006).
10. + T-cell memory by cytokines and costimulators. Immunol. Rev. 211, 23-38 (2006).
11. + CTL after reinfection. J. Immunol. 174(6), 3590-3597 (2005).
12. Kasaian MT, Whitters MJ, Carter LL et al. IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Immunity 16(4), 559-569 (2002).
13. Becker TC, Wherry EJ, Boone D et al. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J. Exp. Med. 195(12), 1541-1548 (2002).
14. Surh CD, Boyman O, Purton JF, Sprent J. Homeostasis of memory T cells. Immunol. Rev. 211, 154-163 (2006).
15. Bradley LM, Haynes L, Swain SL. IL-7: maintaining T-cell memory and achieving homeostasis. Trends Immunol. 26(3), 172-176 (2005).
16. Osborne LC, Dhanji S, Snow JW et al. Impaired CD8 T cell memory and CD4 T cell primary responses in IL-7R a mutant mice. J. Exp. Med. 204(3), 619-631 (2007).
17. Casey KA, Mescher MF. IL-21 promotes differentiation of naive CD8 T cells to a unique effector phenotype. J. Immunol. 178(12), 7640-7648 (2007).
18. + T cells. J. Immunol. 175(2), 755-762 (2005).
19. Randall RE, Goodbourn S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 89(Pt 1), 1-47 (2008).
20. Walzer T, Dalod M, Vivier E, Zitvogel L. Natural killer cell-dendritic cell crosstalk in the initiation of immune responses. Expert Opin. Biol. Ther. 5(Suppl. 1), S49-S59 (2005).
21. Howe RC, Dhiman N, Ovsyannikova IG, Poland GA. Induction of CD4 T cell proliferation and in vitro Th1-like cytokine responses to measles virus. Clin. Exp. Immunol. 140(2), 333-342 (2005).
22. + T cells that proliferate in vitro detected in samples from most viremic subjects and inversely associated with plasma HIV-1 levels. J. Virol. 78(22), 12638-12646 (2004).
23. Wong P, Pamer EG. CD8 T cell responses to infectious pathogens. Annu. Rev. Immunol. 21, 29-70 (2003).
24. Boyman O, Purton JF, Surh CD, Sprent J. Cytokines and T-cell homeostasis. Curr. Opin. Immunol. 19(3), 320-326 (2007).
25. Wilson CB, Marcuse EK. Vaccine safety-vaccine benefits: science and the public's perception. Nat. Rev. Immunol. 1(2), 160-165 (2001).
26. Mossman KL, Ashkar AA. Herpesviruses and the innate immune response. Viral Immunol. 18(2), 267-281 (2005).
27. Brideau-Andersen AD, Huang X, Sun SC et al. Directed evolution of gene-shuffled IFN-α molecules with activity profiles tailored for treatment of chronic viral diseases. Proc. Natl Acad. Sci. USA 104(20), 8269-8274 (2007).
28. Gosselin J, TomoIu A, Gallo RC, Flamand L. Interleukin-15 as an activator of natural killer cell-mediated antiviral response. Blood 94(12), 4210-4219 (1999).
29. Gill N, Ashkar AA. Adaptive immune responses fail to provide protection against genital HSV-2 infection in the absence of IL-15. Eur. J. Immunol. 37(9), 2529-2538 (2007).
30. + memory T cells are IL-15 dependent. J. Exp. Med. 204(4), 951-961 (2007).
31. + T cells in vitro. Blood 102(7), 2541-2546 (2003).
32. + T cells. J. Immunol. 180(7), 4391-4401 (2008).
33. Brady J, Hayakawa Y, Smyth MJ, Nutt SL. IL-21 induces the functional maturation of murine NK cells. J. Immunol. 172(4), 2048-2058 (2004).
34. Wang G, Tschoi M, Spolski R et al. In vivo antitumor activity of interleukin 21 mediated by natural killer cells. Cancer Res. 63(24), 9016-9022 (2003).
35. Brandt K, Bulfone-Paus S, Foster DC, Ruckert R. Interleukin-21 inhibits dendritic cell activation and maturation. Blood 102(12), 4090-4098 (2003).
36. Caprioli F, Sarra M, Caruso R et al. Autocrine regulation of IL-21 production in human T lymphocytes. J. Immunol. 180(3), 1800-1807 (2008).
37. + T cell-B cell collaboration. J. Immunol. 179(9), 5886-5896 (2007).
38. + memory T cell accumulation. Eur. J. Immunol. 37(11), 3069-3077 (2007).
39. Ostiguy V, Allard EL, Marquis M, Leignadier J, Labrecque N. IL-21 promotes T lymphocyte survival by activating the phosphatidylinositol-3 kinase signaling cascade. J. Leukoc. Biol. 82(3), 645-656 (2007).
40. + T cells. J. Immunol. 169(10), 5838-5843 (2002).
41. Ozaki K, Spolski R, Feng CG et al. A critical role for IL-21 in regulating immunoglobulin production. Science 298(5598), 1630-1634 (2002).
42. Waldmann TA. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat. Rev. Immunol. 6(8), 595-601 (2006).
43. Ma A, Koka R, Burkett P. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu. Rev. Immunol. 24, 657-679 (2006).
44. Ohteki T, Tada H, Ishida K et al. Essential roles of DC-derived IL-15 as a mediator of inflammatory responses in vivo. J. Exp. Med. 203(10), 2329-2338 (2006).
45. + T cell homeostasis. J. Exp. Med. 200(7), 825-834 (2004).
46. Grabstein KH, Eisenman J, Shanebeck K et al. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 264(5161), 965-968 (1994).
47. Nishimura H, Yajima T, Naiki Y et al. Differential roles of interleukin 15 mRNA isoforms generated by alternative splicing in immune responses in vivo. J. Exp. Med. 191(1), 157-170 (2000).
48. Tan X, Lefrancois L. Novel IL-15 isoforms generated by alternative splicing are expressed in the intestinal epithelium. Genes Immun. 7(5), 407-416 (2006).
49. Nishimura H, Fujimoto A, Tamura N et al. A novel autoregulatory mechanism for transcriptional activation of the IL-15 gene by a nonsecretable isoform of IL-15 generated by alternative splicing. FASEB J. 19(1), 19-28 (2005).
50. Dubois S, Mariner J, Waldmann TA, Tagaya Y. IL-15Ra recycles and presents IL-15 in trans to neighboring cells. Immunity 17(5), 537-547 (2002).
51. Sato N, Patel HJ, Waldmann TA, Tagaya Y. The IL-15/IL-15Ra on cell surfaces enables sustained IL-15 activity and contributes to the long survival of CD8 memory T cells. Proc. Natl Acad. Sci. USA 104(2), 588-593 (2007).
52. Kobayashi H, Dubois S, Sato N et al. Role of trans-cellular IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance. Blood 105(2), 721-727 (2005).
53. Bulanova E, Budagian V, Duitman E et al. Soluble interleukin IL-15Rα is generated by alternative splicing or proteolytic cleavage and forms functional complexes with IL-15. J. Biol. Chem. 282(18), 13167-13179 (2007).
54. Pasare C, Medzhitov R. Toll-dependent control mechanisms of CD4 T cell activation. Immunity 21(5), 733-741 (2004).
55. Kobayashi N, Takesue M, Kobayashi N et al. Evaluation of Toll-like receptor 4 gene expression of immortalized human liver cell lines. Transplant. Proc. 35(1), 431-432 (2003).
56. Coccia EM, Severa M, Giacomini E et al. Viral infection and Toll-like receptor agonists induce a differential expression of type I and λ interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur. J. Immunol. 34(3), 796-805 (2004).
57. Hon H, Jacob J. Tracking dendritic cells in vivo: insights into DC biology and function. Immunol. Res. 29(1-3), 69-80 (2004).
58. Kuwajima S, Sato T, Ishida K et al. Interleukin 15-dependent crosstalk between conventional and plasmacytoid dendritic cells is essential for CpG-induced immune activation. Nat. Immunol. 7(7), 740-746 (2006).
59. Pulendran B. Division of labor and cooperation between dendritic cells. Nat. Immunol. 7(7), 699-700 (2006).
60. Hultcrantz M, Huhn MH, Wolf M et al. Interferons induce an antiviral state in human pancreatic islet cells. Virology 367(1), 92-101 (2007).
61. Andoniou CE, van Dommelen SL, Voigt V et al. Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nat. Immunol. 6(10), 1011-1019 (2005).
62. Huntington ND, Puthalakath H, Gunn P et al. Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1. Nat. Immunol. 8(8), 856-863 (2007).
63. Ashkar AA, Rosenthal KL. Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection. J. Virol. 77(18), 10168-10171 (2003).
64. Lucas M, Schachterle W, Oberle K, Aichele P, Diefenbach A. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26(4), 503-517 (2007).
65. Liu G, Zhai Q, Schaffner D et al. IL-15 induces IFN-β and iNOS gene expression, and antiviral activity of murine macrophage RAW 264.7 cells. Immunol. Lett. 91(2-3), 171-178 (2004).
66. + T cell immunity in the lung by CpG oligodeoxynucleotides increases protective efficacy of a modified vaccinia Ankara vaccine against lethal poxvirus infection even in a CD4-deficient host. J. Immunol. 177(9), 6336-6343 (2006).
67. + T cell efficacy in vaccination and disease. Nat. Med. 14(6), 623-628 (2008).
68. Masopust D, Vezys V, Wherry EJ, Ahmed R. A brief history of CD8 T cells. Eur. J. Immunol. 37(Suppl. 1), S103-S110 (2007).
69. + effector and memory T cell subsets. Cell. Mol. Immunol. 4(6), 399-405 (2007).
70. Sandau MM, Winstead CJ, Jameson SC. IL-15 is required for sustained lymphopenia-driven proliferation and accumulation of CD8 T cells. J. Immunol. 179(1), 120-125 (2007).
71. + T cell contraction during primary infection. J. Immunol. 176(1), 507-515 (2006).
72. + T cells to interleukin-7 or interleukin-15 stimulates proliferation without differentiation or loss of telomere length. Immunology 119(2), 243-253 (2006).
73. Sauce D, Larsen M, Curnow SJ et al. EBV-associated mononucleosis leads to long-term global deficit in T-cell responsiveness to IL-15. Blood 108(1), 11-18 (2006).
74. Virgin HW. Immune regulation of viral infection and vice versa. Immunol. Res. 32(1-3), 293-315 (2005).
75. Oldstone MB. Viral persistence: parameters, mechanisms and future predictions. Virology 344(1), 111-118 (2006).
76. + T cells in the lung airways. J. Immunol. 178(8), 4721-4725 (2007).
77. Khanna KM, Lepisto AJ, Decman V, Hendricks RL. Immune control of herpes simplex virus during latency. Curr. Opin. Immunol. 16(4), 463-469 (2004).
78. + T cell memory. J. Immunol. 177(12), 8356-8364 (2006).
79. + T cell exhaustion during chronic viral infection. Immunity 27(4), 670-684 (2007).
80. Shin H, Wherry EJ. CD8 T cell dysfunction during chronic viral infection. Curr. Opin. Immunol. 19(4), 408-415 (2007).
81. Wherry EJ, Barber DL, Kaech SM, Blattman JN, Ahmed R. Antigen- independent memory CD8 T cells do not develop during chronic viral infection. Proc. Natl Acad. Sci. USA 101(45), 16004-16009 (2004).
82. Parrish-Novak J, Dillon SR, Nelson A et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408(6808), 57-63 (2000).
83. Coquet JM, Kyparissoudis K, Pellicci DG et al. IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production. J. Immunol. 178(5), 2827-2834 (2007).
84. Ozaki K, Kikly K, Michalovich D, Young PR, Leonard WJ. Cloning of a type I cytokine receptor most related to the IL-2 receptor β chain. Proc. Natl Acad. Sci. USA 97(21), 11439-11444 (2000).
85. Distler JH, Jungel A, Kowal-Bielecka O et al. Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis. Arthritis Rheum. 52(3), 856-864 (2005).
86. Jin H, Carrio R, Yu A, Malek TR. Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or Bim-dependent apoptosis. J. Immunol. 73(1), 657-665 (2004).
87. + cell precursors towards NK cells and acquisition of surface killer Ig-like receptors. Eur. J. Immunol. 33(12), 3439-3447 (2003).
88. Strengell M, Sareneva T, Foster D, Julkunen I, Matikainen S. IL-21 up- regulates the expression of genes associated with innate immunity and Th1 response. J. Immunol. 169(7), 3600-3605 (2002).
89. Bettelli E, Korn T, Kuchroo VK. Th17: the third member of the effector T cell trilogy. Curr. Opin. Immunol. 19(6), 652-657 (2007).
90. Reiner SL. Development in motion: helper T cells at work. Cell 129(1), 33-36 (2007).
91. Wurster AL, Rodgers VL, Satoskar AR et al. Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon γ-producing Th1 cells. J. Exp. Med. 196(7), 969-977 (2002).
92. Suto A, Wurster AL, Reiner SL, Grusby MJ. IL-21 inhibits IFN-γ production in developing Th1 cells through the repression of Eomesodermin expression. J. Immunol. 177(6), 3721-3727 (2006).
93. Nurieva R, Yang XO, Martinez G et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448(7152), 480-483 (2007).
94. Zeng R, Spolski R, Casas E et al. The molecular basis of IL-21-mediated proliferation. Blood 109(10), 4135-4142 (2007).
95. White L, Krishnan S, Strbo N et al. Differential effects of IL-21 and IL-15 on perforin expression, lysosomal degranulation, and proliferation in CD8 T cells of patients with human immunodeficiency virus-1 (HIV). Blood 109(9), 3873-3880 (2007).
96. Spolski R, Leonard WJ. Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu. Rev. Immunol. 26, 57-79 (2008).
97. Dou J, Tang Q, Zhao F et al. Comparison of immune responses induced in mice by vaccination with DNA vaccine constructs expressing mycobacterial antigen 85A and interleukin-21 and bacillus Calmette-Guerin. Immunol. Invest. 37(2), 113-127 (2008).
98. Curtsinger JM, Johnson CM, Mescher MF. CD8 T cell clonal expansion and development of effector function require prolonged exposure to antigen, costimulation, and signal 3 cytokine. J. Immunol. 171(10), 5165-5171 (2003).
99. + T cells responding to self-antigens. J. Exp. Med. 196(3), 323-333 (2002).
100. Sille FC, Visser A, Boes M. T cell priming by tissue-derived dendritic cells: new insights from recent murine studies. Cell. Immunol. 237(2), 77-85 (2005).
101. + T cell expansion and function. J. Exp. Med. 201(1), 139-148 (2005).
102. + T lymphocytes. Cell. Signal. 19(4), 806-816 (2007).
103. Luciano AA, Lederman MM, Valentin-Torres A, Bazdar DA, Sieg SF. Impaired induction of CD27 and CD28 predicts naive CD4 T cell proliferation defects in HIV disease. J. Immunol. 179(6), 3543-3549 (2007).
104. Hendriks J, Gravestein LA, Tesselaar K et al. CD27 is required for generation and long-term maintenance of T cell immunity. Nat. Immunol. 1(5), 433-440 (2000).
105. Gamadia LE, van Leeuwen EM, Remmerswaal EB et al. The size and phenotype of virus-specific T cell populations is determined by repetitive antigenic stimulation and environmental cytokines. J. Immunol. 172(10), 6107-6114 (2004).
106. Sinclair J, Sissons P. Latency and reactivation of human cytomegalovirus. J. Gen. Virol. 87(Pt 7), 1763-1779 (2006).
107. + T cells. Immunol. Rev. 186, 221-233 (2002).
108. Holm C, Nyvold CG, Paludan SR, Thomsen AR, Hokland M. Interleukin-21 mRNA expression during virus infections. Cytokine 33(1), 41-45 (2006).
109. Strengell M, Matikainen S, Siren J et al. IL-21 in synergy with IL-15 or IL-18 enhances IFN-γ production in human NK and T cells. J. Immunol. 170(11), 5464-5469 (2003).
110. Lu S, Wang S, Grimes-Serrano JM. Current progress of DNA vaccine studies in humans. Expert Rev. Vaccines 7(2), 175-191 (2008).
111. Dhama K, Mahendran M, Gupta PK, Rai A. DNA vaccines and their applications in veterinary practice: current perspectives. Vet. Res. Commun. 32(5), 341-356 (2008).
112. Hiromatsu T, Yajima T, Matsuguchi T et al. Overexpression of interleukin-15 protects against Escherichia coli-induced shock accompanied by inhibition of tumor necrosis factor-α-induced apoptosis. J. Infect. Dis. 187(9), 1442-1451 (2003).
113. + T cells. Eur. J. Immunol. 36(5), 1156-1167 (2006).
114. d'Ettorre G, Andreotti M, Carnevalini M et al. Interleukin-15 enhances the secretion of IFN-γ and CC chemokines by natural killer cells from HIV viremic and aviremic patients. Immunol. Lett. 103(2), 192-195 (2006).
115. Li W, Li S, Hu Y et al. Efficient augmentation of a long-lasting immune responses in HIV-1 gag DNA vaccination by IL-15 plasmid boosting. Vaccine 26(26), 3282-3290 (2008).
116. Boyer JD, Robinson TM, Kutzler MA et al. Protection against simian/humanc immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid. Proc. Natl Acad. Sci. USA 104(47), 18648-18653 (2007).
117. Kutzler MA, Robinson TM, Chattergoon MA et al. Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help. J. Immunol. 175(1), 112-123 (2005).
118. Stoklasek TA, Schluns KS, Lefrancois L. Combined IL-15/IL-15Ra immunotherapy maximizes IL-15 activity in vivo. J. Immunol. 177(9), 6072-6080 (2006).
119. + T lymphocytes. Blood 111(4), 2181-2189 (2008).
120. Davis ID, Skak K, Smyth MJ et al. Interleukin-21 signaling: functions in cancer and autoimmunity. Clin. Cancer Res. 13(23), 6926-6932 (2007).
121. de Totero D, Meazza R, Zupo S et al. Interleukin-21 receptor (IL-21R) is up-regulated by CD40 triggering and mediates proapoptotic signals in chronic lymphocytic leukemia B cells. Blood 107(9), 3708-3715 (2006).
122. + T cell responses to achieve durable tumor immunity: comparative evaluation of IL-2, IL-15, and IL-21. J. Immunol. 173(2), 900-909 (2004).
123. + T cell response. J. Exp. Med. 203(9), 2135-2143 (2006).
124. + T cells via antigen cross-presentation. J. Immunol. 176(12), 7288-7300 (2006).
125. + T cells suppress allograft rejection. J. Immunol. 180(1), 113-121 (2008).
126. Vezys V, Masopust D, Kemball CC et al. Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection. J. Exp. Med. 203(10), 2263-2269 (2006).
127. Shin H, Blackburn SD, Blattman JN, Wherry EJ. Viral antigen and extensive division maintain virus-specific CD8 T cells during chronic infection. J. Exp. Med. 204(4), 941-949 (2007).